Rennova Health, Inc.
RNVAOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$4305132
P/E Ratio—
52W High$0.0001
52W Low$0.0001
Rennova Health, Inc. (RNVA) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · RNVA · as of 2026-06-15
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2023-12 | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $18.69M | $13.04M | $3.22M | $7.20M | $16.00M |
| Cost of Revenue | $7.57M | $6.77M | $5.29M | $11.78M | $15.55M |
| Gross Profit | $11.11M | $6.27M | ($2.07M) | ($4.58M) | $0.45M |
| Gross Margin %(computed) | 59.46% | 48.08% | -64.16% | -63.66% | 2.81% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $9.44M | $7.22M | $7.51M | $11.66M | $0.00M |
| Total Operating Expenses | $9.75M | $7.68M | $10.45M | $12.61M | $16.15M |
| Operating Income | $1.37M | ($1.41M) | ($12.52M) | ($17.20M) | ($15.70M) |
| Operating Margin %(computed) | 7.31% | -10.81% | -388.37% | -238.82% | -98.10% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $1.45M | $2.26M | $3.19M | $9.84M | $21.73M |
| Income Before Tax | ($0.31M) | ($3.04M) | ($5.09M) | ($18.95M) | ($46.58M) |
| Income Tax Expense | $0.24M | $0.31M | $0.18M | ($1.31M) | $0.00M |
| Net Income | ($7.73M) | ($3.29M) | $5.61M | ($18.34M) | ($48.03M) |
| Net Margin %(computed) | -41.36% | -25.26% | 173.86% | -254.71% | -300.15% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.00 | $-0.03 | $-913.37 | $-93864830.67 | $-3077380701.32 |
| Wtd Avg Shares | 32825.52M | 9992.24M | 0.55M | 0.00M | 0.00M |
| EBITDA | $1.45M | ($0.31M) | ($1.26M) | ($8.41M) | ($24.06M) |
| EBITDA Margin %(computed) | 7.76% | -2.38% | -39.19% | -116.81% | -150.33% |
Data source: Financial Modeling Prep · Last updated: 2026-06-15 · USD · M
Explore more Rennova Health, Inc. data
About Rennova Health, Inc. (RNVA) Income Statement
Rennova Health, Inc. (RNVA) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2023, RNVA reported revenue of $0.02B, gross profit of $0.01B (gross margin 59.46%), and net income of ($0.01B) — a net profit margin of -41.36%.
Frequently asked questions
RNVA · 4 questionsRennova Health, Inc. (RNVA) reported revenue of $0.02B for 2023, up 43.3% year-over-year.
RNVA revenueRNVA salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15